DEF 14A

Company

International Stem Cell CORP

Filed

October 29, 2014

Period of Report

December 4, 2014

Accession Number

0001193125-14-387239

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →